UBS Group’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$914K Sell
65,022
-31,764
-33% -$460K ﹤0.01% 5619
2025
Q4
$1.49M Buy
96,786
+76,955
+388% +$903K ﹤0.01% 5225
2025
Q3
$171K Sell
19,831
-1,207
-6% -$9.86K ﹤0.01% 6762
2025
Q2
$210K Buy
21,038
+20,786
+8,248% +$707K ﹤0.01% 6688
2025
Q1
$22.2K Sell
252
-21
-8% -$1.84K ﹤0.01% 8158
2024
Q4
$25.3K Buy
273
+92
+51% +$7.93K ﹤0.01% 7737
2024
Q3
$13.3K Sell
181
-135
-43% -$8.71K ﹤0.01% 7597
2024
Q2
$18.3K Sell
316
-5
-2% -$3.32K ﹤0.01% 7352
2024
Q1
$332K Sell
321
-29
-8% -$22.1K ﹤0.01% 5503
2023
Q4
$277K Buy
350
+30
+9% +$15.3K ﹤0.01% 5557
2023
Q3
$152K Buy
320
+234
+272% +$127K ﹤0.01% 5553
2023
Q2
$51.4K Sell
86
-85
-50% -$54.4K ﹤0.01% 6461
2023
Q1
$121K Buy
+171
New +$142K ﹤0.01% 5774
2022
Q4
Sell
-46
Closed -$26K 10718
2022
Q3
$26K Buy
+46
New +$30.7K ﹤0.01% 7035
2022
Q1
Sell
-14
Closed -$6K 10231
2021
Q4
$6K Sell
14
-17
-55% -$8.6K ﹤0.01% 9249
2021
Q3
$23K Sell
31
-28
-47% -$15.7K ﹤0.01% 7005
2021
Q2
$47K Buy
+59
New +$47.1K ﹤0.01% 6487

Other funds holding JBIO